BIOGEN INC. 8-K

What Happened
On March 11, 2026 Biogen Inc. filed an Form 8‑K (Item 5.02) announcing that Susan H. Alexander, the Company’s Chief Legal Officer, will depart effective as of the end of May 2026. The company said it has initiated a search to identify its next Chief Legal Officer.

Key Details

• Filing date: March 11, 2026 (Form 8‑K, Item 5.02).
• Executive departing: Susan H. Alexander, Chief Legal Officer.
• Effective departure timing: end of May 2026.
• Company action: has initiated a search for a successor; no replacement or additional terms disclosed in the filing.

Why It Matters
A change in the chief legal officer is material for investors because the CLO oversees legal, regulatory compliance, and litigation matters that can affect operations and risk exposure. The 8‑K confirms the departure date and that a search is underway, but provides no details on a successor or transitional arrangements — investors may watch for follow-up announcements about an interim leader or a permanent hire.